A detailed history of Foster Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Foster Group, Inc. holds 29,027 shares of PFE stock, worth $860,940. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,027
Previous 29,664 2.15%
Holding current value
$860,940
Previous $823,000 1.34%
% of portfolio
0.03%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $16,090 - $18,855
-637 Reduced 2.15%
29,027 $812,000
Q1 2024

Apr 09, 2024

BUY
$25.89 - $29.73 $259,547 - $298,043
10,025 Added 51.05%
29,664 $823,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $117,609 - $137,474
-3,665 Reduced 15.73%
19,639 $651,000
Q2 2023

Jul 10, 2023

BUY
$36.12 - $41.79 $161,998 - $187,428
4,485 Added 23.83%
23,304 $854,000
Q1 2023

Apr 06, 2023

BUY
$39.39 - $51.28 $8,350 - $10,871
212 Added 1.14%
18,819 $767,000
Q4 2022

Jan 23, 2023

SELL
$41.75 - $54.5 $3,924 - $5,123
-94 Reduced 0.5%
18,607 $0
Q3 2022

Oct 13, 2022

BUY
$43.76 - $53.42 $15,578 - $19,017
356 Added 1.94%
18,701 $818,000
Q2 2022

Jul 25, 2022

BUY
$46.53 - $55.17 $219,575 - $260,347
4,719 Added 34.63%
18,345 $962,000
Q1 2022

Apr 22, 2022

SELL
$45.75 - $56.69 $503 - $623
-11 Reduced 0.08%
13,626 $705,000
Q4 2021

Feb 02, 2022

SELL
$41.32 - $61.25 $27,808 - $41,221
-673 Reduced 4.7%
13,637 $805,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $117 - $151
3 Added 0.02%
14,310 $615,000
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $11,024 - $12,488
307 Added 2.19%
14,307 $560,000
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $100 - $113
3 Added 0.02%
14,000 $507,000
Q4 2020

Jan 21, 2021

BUY
$33.47 - $42.56 $468,479 - $595,712
13,997 New
13,997 $515,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Foster Group, Inc. Portfolio

Follow Foster Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foster Group, Inc. with notifications on news.